Evidence map›Paper›PMID 20694539›Full record

ReviewCerebellum (London, England)2012

Purinergic modulation of granule cells.

Raphaël Courjaret, María Teresa Miras-Portugal, Joachim W Deitmer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cerebellum (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Neuroprotection Mediated by P2Y13 Nucleotide Receptors in Neurons.Computational and structural biotechnology journal · 2015
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 4 countries.

Raphaël CourjaretAbteilung für Allgemeine Zoologie, FB Biologie, TU Kaiserslautern, Postfach 3049, 67653 Kaiserslautern, Germany. rac2017@qatar-med.cornell.edu
María Teresa Miras-Portugal
Joachim W Deitmer
Universidad Complutense de Madrid · ESUniversity of Kaiserslautern · DEWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular purines exert their action in the nervous system through purinergic neurotransmission and neuromodulatory processes. Among brain areas, efforts have been made to investigate the purinergic modulation of the cerebellar cortex. In addition, the use of granule cells in culture as a neuronal in vitro model provided important information about the implications of purines in mechanisms such as cell survival and differentiation. This short review is focused on the function of purines in the physiology of granule cells in situ and in vitro. In situ, adenosine has been shown to inhibit some of the glutamatergic and GABAergic synaptic inputs to granule cells. The inhibition of GABA input allows an increase in the excitability of the cell while the output (parallel fibers) of granule cells is also down-regulated by adenosine, suggesting a complex mode of regulation by purines. In vitro, granule cells have been shown to express members of all classes of purinergic receptors, P2X (ionotropic), P2Y (metabotropic) and adenosine receptors. The specific expression of these receptors and the downstream signaling pathways coupling them to cell survival and growth have been extensively studied.

Indexed as

AdenosineAnimalsCerebellar CortexCytoplasmic GranulesHumansNeuronsNeurotransmitter AgentsReceptors, PurinergicAdenosineNeurotransmitter AgentsReceptors, Purinergic

Identifiers

PMID20694539
OpenAlexW2091540254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.